Department of Medicine and Surgery, University of Salerno, Italy.
Int J Immunopathol Pharmacol. 2012 Apr-Jun;25(2):425-33. doi: 10.1177/039463201202500212.
The aim of this study is to evaluate some inflammatory parameter changes in septic shock patients and their possible correlation with clinical outcome, in particular when continuous veno-venous hemofiltration (CVVH) treatment is required. Considering the objective difficulty in enrolling this kind of patient, a preliminary study was initiated on seventeen septic shock patients admitted to a medical and surgical ICU. The mRNA expression of Toll-like receptor (TLR)-1, TLR-2, TLR-4, TLR-5, TLR-9, TNFα, IL-8 and IL-1β was assessed, the plasmatic concentrations of IL-18, IL-2, IL-10 and TNFα were measured on the day of sepsis diagnosis and after 72 h. In those patients who developed acute renal failure unresponsive to medical treatment and who underwent CVVH treatment the same parameters were measured every 24 h during CVVH and after completion of the treatment. On sepsis diagnosis, gene expression of TLRs was up-regulated compared to the housekeeping gene in all the patients. After 72 h, in 35% of the patients a down-regulation of these genes was found compared to day 1, but it was not associated with a reduction of cytokine serum levels or improved clinical signs, better outcome or reduced mortality. After high volume hemofiltration treatment, cytokine serum levels and TLR expression were not significantly modified. In conclusion, considering the not numerous number of cases, from our preliminary study, we cannot certainly correlate TLR over-expression in septic shock patients with severity or outcome scores.
本研究旨在评估感染性休克患者的一些炎症参数变化及其与临床结果的可能相关性,特别是在需要连续静脉-静脉血液滤过 (CVVH) 治疗时。考虑到招募这种患者的客观困难,我们对 17 名入住内科和外科重症监护病房的感染性休克患者进行了初步研究。评估了 Toll 样受体 (TLR)-1、TLR-2、TLR-4、TLR-5、TLR-9、TNFα、IL-8 和 IL-1β 的 mRNA 表达,在感染性休克诊断当天和 72 小时后测量了血浆中 IL-18、IL-2、IL-10 和 TNFα 的浓度。在那些因急性肾损伤而对药物治疗无反应并接受 CVVH 治疗的患者中,在 CVVH 期间和治疗完成后每 24 小时测量相同的参数。在感染性休克诊断时,与管家基因相比,所有患者的 TLR 基因表达均上调。72 小时后,35%的患者与第 1 天相比,这些基因的表达下调,但与细胞因子血清水平降低、临床症状改善、预后改善或死亡率降低无关。在高容量血液滤过治疗后,细胞因子血清水平和 TLR 表达没有显著改变。总之,考虑到病例数量不多,我们的初步研究不能确定感染性休克患者 TLR 过度表达与严重程度或预后评分之间的相关性。